Inflammation and limited adaptive immunity predict worse outcomes on immunotherapy in head and neck cancer by Lisa Paschold, Christoph Schultheiss, Paul Schmidt-Barbo, Konrad Klinghammer, Dennis Hahn, Mareike Tometten, Philippe Schafhausen, Markus Blaurock, Anna Brandt, Ingunn Westgaard, Simone Kowoll, Alexander Stein, Axel Hinke, Mascha Binder

Get full text